Cite
HARVARD Citation
Daniele, G. et al. (2021). Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study. International journal of gynecological cancer. 31 (6), pp. 875-882. [Online].